Literature DB >> 9466551

Molecular analysis of Plasmodium vivax relapses using the MSP1 molecule as a genetic marker.

K Kirchgatter1, H A del Portillo.   

Abstract

Plasmodium vivax has hepatocytic dormant stages, hypnozoites, that cause relapses. This work compared paired isolates from primary attacks and relapses obtained from 10 individuals in Brazil using the merozoite surface protein 1 gene, PvMSP1, as a genetic marker. Four samples from primary attacks contained genetically mixed parasites harboring the 2 major PvMSP1 allelic forms. PCR revealed the presence of these 2 forms in the relapse parasites of 2 patients, demonstrating that the activation of hypnozoites is not clonal. DNA sequences from paired primary/relapse samples demonstrated that the parasites from the primary attack are identical to those in relapse samples in which the same allele forms were detected in both infections. Studies on the naturally acquired humoral immune responses of these patients against a recombinant protein expressing the C-terminus PvMSP1 demonstrated an increase in the titers, affinity maturation, and predominance of the IgG1 subclass during the relapse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466551     DOI: 10.1086/517389

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Chloroquine resistance in Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 2.  Uncovering the transmission dynamics of Plasmodium vivax using population genetics.

Authors:  Alyssa E Barry; Andreea Waltmann; Cristian Koepfli; Celine Barnadas; Ivo Mueller
Journal:  Pathog Glob Health       Date:  2015-04-18       Impact factor: 2.894

3.  A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies.

Authors:  I S Soares; J W Barnwell; M U Ferreira; M Gomes Da Cunha; J P Laurino; B A Castilho; M M Rodrigues
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

4.  Genetic diversity of Plasmodium vivax malaria in China and Myanmar.

Authors:  Daibin Zhong; Mariangela Bonizzoni; Guofa Zhou; Guangze Wang; Bin Chen; Anne Vardo-Zalik; Liwang Cui; Guiyun Yan; Bin Zheng
Journal:  Infect Genet Evol       Date:  2011-05-23       Impact factor: 3.342

5.  Therapeutic responses to different antimalarial drugs in vivax malaria.

Authors:  S Pukrittayakamee; A Chantra; J A Simpson; S Vanijanonta; R Clemens; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

6.  Evolutionary dynamics of the immunodominant repeats of the Plasmodium vivax malaria-vaccine candidate circumsporozoite protein (CSP).

Authors:  Aarti Patil; Pamela Orjuela-Sánchez; Mônica da Silva-Nunes; Marcelo U Ferreira
Journal:  Infect Genet Evol       Date:  2010-01-25       Impact factor: 3.342

7.  Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection.

Authors:  I P Ceravolo; B A M Sanchez; T N Sousa; B M Guerra; I S Soares; E M Braga; A M McHenry; J H Adams; C F A Brito; L H Carvalho
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

8.  Evaluation of Plasmodium vivax isolates in Thailand using polymorphic markers Plasmodium merozoite surface protein (PvMSP) 1 and PvMSP3.

Authors:  Nutnicha Suphakhonchuwong; Wanna Chaijaroenkul; Kanchana Rungsihirunrat; Kesara Na-Bangchang; Jiraporn Kuesap
Journal:  Parasitol Res       Date:  2018-10-10       Impact factor: 2.289

9.  Microgeographical differences of Plasmodium vivax relapse and re-infection in the Peruvian Amazon.

Authors:  Raul Chuquiyauri; Pablo Peñataro; Kimberly C Brouwer; Manuel Fasabi; Maritza Calderon; Sonia Torres; Robert H Gilman; Margaret Kosek; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

10.  Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana.

Authors:  Matthieu Hanf; Aurélia Stéphani; Célia Basurko; Mathieu Nacher; Bernard Carme
Journal:  Malar J       Date:  2009-12-04       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.